Search - tctmd.com

Displaying 201 - 220 of 229

Sort: Relevancy | Date

News Industry News

InspireMD Announces Voluntary Field Action for MGuard™ Prime EPS

April 30, 2014

News Daily News

Transradial Access Feasible, Beneficial in Cardiogenic Shock Patients

Jason Kahn

April 10, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Daily News

Study Explores Malpractice Lawsuits Stemming from Interventional Cardiology

Caitlin E. Cox

September 20, 2013

News Daily News

Surgery Best for Long-term Management of Infants with Aortic Stenosis

August 23, 2013

News Daily News

Angioplasty Offers Good Prognosis for Children with Bilateral Peripheral Pulmonary Stenosis

August 23, 2013

News Industry News

Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease

August 16, 2013

News Daily News

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

July 24, 2013

News Industry News

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

June 11, 2013

News Industry News

Medtronic Announces FDA Clearance and First Uses of New Oxygenation System for Adult Cardiac Surgery

April 02, 2013

News Industry News

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 11, 2013

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Daily News

AAA Screening Good for Men but Rescreening May Be Even Better

L.A. McKeown

July 09, 2012

News Daily News

Myocardial Injury Common After TAVR

June 28, 2012

News Daily News

TEVAR Affirmed as First-line Therapy for Traumatic Thoracic Aorta Injury

L.A. McKeown

March 21, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

News Industry News

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 08, 2011

Advertisement

InspireMD Announces Voluntary Field Action for MGuard™ Prime EPS

Transradial Access Feasible, Beneficial in Cardiogenic Shock Patients

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Survival After Septal Ablation for HOCM Similar to General Population

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Study Explores Malpractice Lawsuits Stemming from Interventional Cardiology

Surgery Best for Long-term Management of Infants with Aortic Stenosis

Angioplasty Offers Good Prognosis for Children with Bilateral Peripheral Pulmonary Stenosis

Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

Medtronic Announces FDA Clearance and First Uses of New Oxygenation System for Adult Cardiac Surgery

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

AAA Screening Good for Men but Rescreening May Be Even Better

Myocardial Injury Common After TAVR

TEVAR Affirmed as First-line Therapy for Traumatic Thoracic Aorta Injury

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content